Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @MedicalOmnix
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @MedicalOmnix
-
but “…the progress we see is being overshadowed by our increasing reliance on just a handful of companies. We can’t take their commitment for granted. It is not too late to prevent irreparable damage to the global supply of antibiotic medicines and vaccines,” says Jayasree Iyer
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An important report from
@AtMIndex. The 2020 Antimicrobial Resistance Benchmark has evaluated how the most important players in the antibiotic market are addressing the rise of resistance and the global need for appropriate access to antibiotics ...https://accesstomedicinefoundation.org/publications/2020-antimicrobial-resistance-benchmark …Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
OmnixMedical proslijedio/la je Tweet
New from
@cvdall: WHO reports that, since 2017, 8 new antibiotics have been approved, but only two meet at least one innovation criteria, and the rest are derivatives of known antibiotic classes +@AtMIndex warns that the bulk of R&D is being carried out by just a few companieshttps://twitter.com/CIDRAP/status/1220071701511331840 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
OmnixMedical proslijedio/la je Tweet
Risk of pandemics? Rising. Drugmakers’ ability to respond? It may be falling,
@maxnisen writes https://www.bloomberg.com/opinion/articles/2020-01-23/drug-industry-may-lack-pandemic-preparedness … via@bopinionHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
By mimicking insect immunity, OMN6 will save the lives of millions suffering from infections involving antibiotic-resistant bacteria. Watch us as we continue to develop this game-changing drug and win the war against infectious disease.
#Abaumannii#amr#antimicrobialpeptidespic.twitter.com/dxkGicZzAc
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Omnix Medical's CSO, Dr. Niv Bachnoff gave an outstanding presentation to a full house at
#BiotechShowcase during#jpmweek which was very well-received!#partneringconference#superbugspic.twitter.com/IWULltXjuP
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
OmnixMedical proslijedio/la je Tweet
As #AMR remains to be a hot topic in health sector worldwide. Pharmaceutical companies are still not increasing the speed to discover new effective#antibiotics And new available#antibiotics are still developing resistance .let us increase awareness concerning with#AMRpic.twitter.com/nkHufuzIhf
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
OmnixMedical proslijedio/la je Tweet
Improving antibiotic use will save lives and help us combat
#AntibioticResistance.#CDCARthreats http://bit.ly/CDCARthreats pic.twitter.com/FoA51uITsA
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
OmnixMedical proslijedio/la je Tweet
Did you miss our updated visuals for the new
#CDCARthreats report? Download 3D images, infographics, illustrations & more on#AntibioticResistance here: http://bit.ly/ARvisuals .Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
OmnixMedical proslijedio/la je Tweet
Omnix Medical Ltd. https://buff.ly/2Pe1acc OMN6, currently in IND-enabling studies, is developed for the treatment of severe or life-threatening Hospital/Ventilator-Associated Bacterial Pneumoniae (HABP / VABP)
#biotechshowcasepic.twitter.com/jicX55j8Uo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
OmnixMedical proslijedio/la je Tweet
As part of the
#GlobalAMRChallenge, Opal Biosciences,@ND4BB_ENABLE, Omnix Medical, and@Bioversys commit to research and develop new pharmaceuticals to treat life-threatening and hard-to-treat infections. Learn more: http://bit.ly/2xe2dP2 pic.twitter.com/LdHLYqBnyD
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
OmnixMedical proslijedio/la je Tweet
Omnix Medical Ltd. https://buff.ly/2Pe1acc OMN6, currently in IND-enabling studies, is developed for the treatment of severe or life-threatening Hospital/Ventilator-Associated Bacterial Pneumoniae (HABP / VABP)
#biotechshowcasepic.twitter.com/Ucg4Z4nZMw
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Omnix is looking for a strategic partner and investor to bring OMN6 to clinical dev. The Omnix team looks forward to meeting you at
#JPM2020 in SF and will be presenting at#BiotechShowcase on 1/13. DM to schedule a meeting#infectiousdisease#lifesciences#drugdevelopmentPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The company’s lead drug – OMN6 – targets
#Superbugs. OMN6 is an antimicrobial peptide for the treatment of A.baumannii, an ESKAPE pathogen. OMN6 is effective where standard of care drugs fail. It will shorten hospitalization time and reduce additional healthcare costs.Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Inspired by the innate immune system of insects, employing a strategy that has been proven very efficient for 250 million years, Omnix Medical is developing an arsenal of novel antibiotic agents targeting multidrug-resistant
#MDR bacteria.Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Modern medicine relies on antibiotics. 1/2 of all hospitalized patients receive at least 1 antimicrobial drug on a given day, 25% take 2+. It's difficult to envisage a world wo antibiotic drugs. Yet, AMR is rapidly spreading rendering many antimicrobial drugs useless.
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
OmnixMedical proslijedio/la je Tweet
Last week, I wrote about how better communication can improve how people engage with the issue of drug resistance, and strengthen efforts to
#StopSuperbugs. Read about how this work has changed the language I use at https://www.linkedin.com/posts/jeremyknoxwellcome_publichealth-globalhealth-stopsuperbugs-activity-6610476756908552192-G-Hh …https://twitter.com/wellcometrust/status/1207299988444848130 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Omnix is looking for a strategic partner and investor to bring OMN6 to clinical development. We are available to meet at
#JPMorgan2020 and will be presenting at#BiotechShowcase on Jan. 13. DM to schedule a partnering meeting.#angelinvestors#lifesciences#drugdevelopmentPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Omnix Medical is developing OMN6, an antimicrobial peptide for the treatment of Acinetobacter baumannii, an ESKAPE pathogen. OMN6 is effective where standard of care drugs fail. OMN6 will shorten hospitalization time and reduce additional healthcare costs.
#AMR#infectiousdiseasePrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Talking about the 'antibiotic apocalypse' is alarming, not persuasive